Revenue FY2025
$9.47B
Net Income
$2.67B
EPS (Basic)
$6.03
Net Margin
28.2%
ROE
80.2%
Total Equity
$3.33B
Shares Out
413M
Zoetis Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 11 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Ruane Cunniff
Ruane Cunniff
$169.1M
1.6%
(3.0%)
Tweedy Browne
Tweedy Browne
$40.0M
0.6%
NEW
Mairs & Power
Mairs & Power
$33.6M
0.3%
+54.2%
Platinum Investment Management
Platinum Investment Management
$0.7M
0.2%
(76.2%)
Renaissance Technologies
Renaissance Technologies
$100.8M
0.1%
+456.9%
Polen Capital Management
Polen
$23.0M
0.1%
(92.4%)
Soros Fund Management
Soros family office
$2.0M
0.0%
NEW
Markel Group
Tom Gayner
$4.8M
0.0%
NEW
Capital Research Global Investors
Capital Research Global Investors
$70.5M
0.0%
(30.4%)
Bridgewater Associates
Bridgewater Associates
$9.6M
0.0%
+164.5%
Alps Advisors
Alps Advisors
$2.1M
0.0%
+14.1%
Insider Transactions
Reading stored insider transactions…